Dr. J Sample Magee, MD

Dr. Magee practices at Northeast Florida Endocrine and Diabetes Associates PA in Jacksonville, Florida.

Dr. Magee's NPI, 1801890389, was assigned on June 13, 2005. Dr. Magee graduated from Perelman School of Med at the University of Pennsylvania in 1976. Dr. Magee holds Florida license ME30740.

Dr. Magee's primary practice is Northeast Florida Endocrine and Diabetes Associates PA, at 915 Monroe W St, Jacksonville, FL 32204 in Duval County. The practice phone is (904) 384-2240.

Dr. Magee's primary practice is Northeast Florida Endocrine and Diabetes Associates PA in Jacksonville, Florida. Dr. Magee is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Northeast Florida Endocrine and Diabetes Associates. Dmand AI also links Dr. Magee to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Magee practices, 5 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Magee's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Magee is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Magee is licensed in Florida.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, hypercalcemia, osteoporosis, overactive thyroid, parathyroid gland disorder and underactive thyroid among the conditions Dr. Magee treats.

CMS data shows 2,042 Medicare services from Dr. Magee across 7 procedure codes in 2024, for 512 Medicare patients. Medicare paid $115,736 for them. Every service was in an office.

CMS counts 512 Medicare patients who saw Dr. Magee in 2024. The largest group is 65 to 74, with 216 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Magee's median patient age at 71, with 66% women.

In 2024, Dr. Magee wrote 5,816 Medicare Part D claims for 607 patients. 42% of them were for generic drugs. CMS names the drug for 5,381 of them, across 81 drugs with 11 or more claims each, at $2,113,682 in total drug cost. In 2023, CMS named 4,500 claims across 81 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Magee for performance year 2024, reported through an alternative payment model (APM). Dr. Magee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Magee as offering telehealth.

Dmand AI links 1 paper to Dr. Magee. Dr. Magee's most frequent co-authors are Nancy Reed Kelly, MD, MPH and Russell Wesley Steele, MD.

Dmand AI links Dr. Magee to 3 clinical trials. Conditions studied include Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 and Non-alcoholic Fatty Liver Disease. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Magee that name 4 trials.

CMS Open Payments shows 630 general payments to Dr. Magee from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Abbott Laboratories paid the most, $1,971. It also lists 9 research payments totaling $108,060 from 2017 to 2024, naming 4 clinical trials.

Dmand AI lists 1 award for Dr. Magee, most recently Top Doctors: Florida in 2000.

Dr. Magee graduated from Perelman School of Med at the University of Pennsylvania in 1976.

Dr. Magee is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.